// App-Quantinova.ai

443 : Prognostic significance of CXCL12 protein levels in high-grade serous ovarian carcinoma

Researchers

Presenter

  • Laurence Buisseret

Principal Investigators

  • Vincent Delisle

  • Laudine Communal

  • Sandra Pommey

  • John Stagg

Medical Centers

  • CRCHUM, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • High grade serous ovarian cancer

  • Gynaecological cancer

  • Solid malignancies

Biomarkers

  • C-X-C motif chemokine receptor 4

  • Stromal cell-derived factor 1

Drug/Treatment

  • CXCL12

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved